Recent Quotes (30 days)

You have no recent quotes
chg | %

Taylor Wimpey plc news

   Watch this stock
Showing stories 1 - 8 of about 8   

Articles published

TW 203.90 -0.70 (-0.34%)
price chart
It's time to get over the gilt complex
The unending flight to quality in sovereign bonds has seen gilt prices soar and yields sink to levels that have rarely, if ever, been seen.
How to invest in fine wines
Philip Haden, director of financial advisers McCarthy Taylor, suggests investors look for the most tax-efficient wrapper to hold wine.
Face off: BlackRock Gold & General vs BlackRock World Mining Trust
Commodity funds have been seen as the investment choice of the market bull. They beat markets on the way up, but then suffer as sentiment turns, but can prove profitable for those who can stand the ride.
Are global bond funds a good place to be?
Bonds have assumed increasing importance in investors' portfolios recently, creating a need for further diversification from sterling-denominated issues.
Chart of the Day: Europe's top dividend yielding stocks
BAE Systems PLC (BAES.L). Add To Favourites. In Favourites. Register or Sign in to receive email alerts for items in your favourites whenever we write about them.
FDA Rejects Ariad, Merck's Sarcoma Drug Ridaforolimus
If approved, ridaforolimus would compete with GlaxoSmithKline Plc's (GSK, GSK.L) Votrient, which received FDA approval in April for expanded use on patients with soft-tissue sarcomas who have had chemotherapy.
Alnylam Pharma Names Oved Amitay Vice President, Head Of Commercial
Alnylam Pharmaceuticals Inc. (ALNY), an RNA interference therapeutics company, on Wednesday said it appointed Oved Amitay to the newly created position of Vice President, Head of Commercial.
FDA Okays Arena's Lorcaserin As First Anti-Obesity Drug In Decade
Currently, Roche's Xenical, a prescription anti-obesity drug, and GlaxoSmithKline plc's (GSK) Alli, are the two FDA-approved drugs for obesity in the market, which is virtually untapped.